logo

For the Inventor, By the Inventor

Berlin, Germany

Eberhard Schroder

USPTO Granted Patents = 15

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 145(Granted Patents)


Company Filing History:

goldMedal15 out of 1,384 
 
Schering Aktiengesellschaft
 patents

Years Active: 1976-1981

Loading Chart...
15 patents (USPTO):Explore Patents
1. 4289777 - Quinolonecarboxylic acid derivatives and pharmaceutical preparations (1981-09-15),
2. 4244960 - Indanyl derivatives and their use (1981-01-13),
3. 4117135 - Novel 5,6,7,8-tetrahydro-5-quinolines and their use as anti-inflammatory (1978-09-26),
4. 4057640 - 5,6,7,8:Tetrahydrocarbazole-1-carboxylic acid derivatives (1977-11-08),
5. 4053472 - 2-(5-Nitro-2-imidazolyl)-benzimidazoles (1977-10-11),
6. 4042706 - Novel anti-inflammatory pyrazole derivatives and preparation thereof (1977-08-16),
7. 4032567 - Triiodoisophthalic acid monoamino acid amides, process for the (1977-06-28),
8. 4020164 - Benzomorphan derivatives (1977-04-26),
9. 3966732 - Nitroimidazolyl pyrimidines (1976-06-29),
10. 3962471 - Indolylacetylamino acid derivatives, process for their preparation, and (1976-06-08),
11. 3962453 - Novel pyrazolyloxyacetic acid derivatives and process for the (1976-06-08),
12. 3960949 - 1,2-Biguanides (1976-06-01),
13. 3956295 - Carbazole derivatives (1976-05-11),
14. 3953501 - Triiodoisophthalic acid monoamino acid amides (1976-04-27),
15. 3952007 - Processes for preparing (1976-04-20),

Title: Eberhard Schroder: Pioneering Innovations in Pharmaceutical Chemistry

Introduction

Eberhard Schroder is a notable inventor based in Berlin, Germany, recognized for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio comprising 15 patents, his work primarily revolves around innovative chemical compounds with therapeutic applications.

Latest Patents

Schroder's latest patents showcase his expertise in the development of novel compounds. One of his significant patents is focused on quinolonecarboxylic acid derivatives, characterized by their unique structural properties that enable notable pharmacological activities. Another salient invention pertains to indanyl derivatives, which are designed for various applications, including herbicidal activity. These compounds are crucial in advancing therapeutic options in modern medicine.

Career Highlights

Eberhard Schroder's career is affiliated with Schering Aktiengesellschaft, a prominent pharmaceutical company. Throughout his tenure, he has been instrumental in the research and development of therapeutic agents that address critical health challenges. His extensive work in this field reflects a commitment to innovation and excellence in pharmaceutical sciences.

Collaborations

Collaboration plays a vital role in Schroder's success. He has worked alongside esteemed colleagues such as Clemens Rufer and Helmut Biere, who share his passion for advancing pharmaceutical research. Together, they have contributed to the development of groundbreaking technologies and compounds within the industry.

Conclusion

Eberhard Schroder exemplifies the spirit of innovation in the pharmaceutical sector. With his extensive patent portfolio and collaborations with leading professionals in the field, he continues to make significant strides in improving human health through inventive chemical solutions. His work stands as a testament to the importance of research and development in creating effective pharmacological preparations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…